Latest News: Proscia profiled in KLAS Emerging Company Spotlight.DOWNLOAD THE REPORT

Gain access to a portfolio of best-in-class AI applications on the Concentriq enterprise pathology platform.

Deploy diagnostic and research applications directly into your workflow with Concentriq. Browse our rapidly growing precision medicine AI portfolio.

Automated QC
Automated QC
Tissue Type: Various
Vendor: Proscia
Automated QC
Detects and segments images with artifacts to help optimize the quality control process and improve the quality of data driving your research.
​Prostate Workflow
​Prostate Workflow
Tissue Type: Prostate
Vendor: Ibex
CE-IVD
​Prostate Workflow
​Clinical-grade solution that assists pathologists in improving the detection and grading of prostate cancer.
Breast Workflow
Breast Workflow
Tissue Type: Breast
Vendor: Ibex
CE-IVD
Breast Workflow
​Clinical-grade solution that assists pathologists in improving the detection and grading of breast cancer.
Gastric Workflow
Gastric Workflow
Tissue Type: Gastric
Vendor: Ibex
CE-IVD
Gastric Workflow
Clinical-grade solution that assists pathologists in improving the detection of gastric cancer and other clinical findings.
​PD-L1
​PD-L1
Tissue Type: Lung
Vendor: ​Visiopharm
CE-IVD
​PD-L1
​Automatically identify invasive cancer areas, count tumor cells based on PD-L1 expression, and calculate the Tumor Proportion Score for NSCLC cases.
HER2
HER2
Tissue Type: Breast
Vendor: ​Visiopharm
CE-IVD
HER2
​Automatically calculate a Score, corresponding to ASCO/CAP guidelines on HER2 IHC scoring, and determine the connectivity of HER-2 stained membrane in brightfield WSIs of breast tissue sections.
​Ki-67
​Ki-67
Tissue Type: Breast
Vendor: ​Visiopharm
CE-IVD
​Ki-67
Automatically identify invasive cancer areas, count tumor nuclei based on Ki-67 expression, and calculate the proliferation index.
ER
ER
Tissue Type: Breast
Vendor: ​Visiopharm
CE-IVD
ER
​Quantify ER expression via automated calculation of positive percentage and allred score for regions of interest.
PR
PR
Tissue Type: Breast
Vendor: ​Visiopharm
CE-IVD
PR
​Quantify PR expression via automated calculation of positive percentage and allred score for regions of interest.
​Metastasis Detection
​Metastasis Detection
Tissue Type: Lymph node (Breast or Colorectal)
Vendor: ​Visiopharm
CE-IVD
​Metastasis Detection
​AI/deep learning-assisted metastasis detection in lymph nodes simplifies assessment for breast and colorectal adenocarcinoma.
​Histotype Px
​Histotype Px
Tissue Type: ​Colorectal
Vendor: ​DoMore Diagnostics
CE-IVD
Pipeline
​Histotype Px
​Digital biomarker that automatically predicts the outcome of a colorectal patient’s cancer. Combined with tumor and lymph node status, the test report provides information about patient's risk profile and 5-year cancer-specific survival to inform the decision to use adjuvant chemotherapy.
​Stratipath Breast
​Stratipath Breast
Tissue Type: ​Breast
Vendor: ​Stratipath
CE-IVD
Pipeline
​Stratipath Breast
AI-based precision diagnostic that analyzes cancer tissue to enable the identification of patients with increased risk of disease progression
​PD-L1 (Lung)
​PD-L1 (Lung)
Tissue Type: Lung
Vendor: Mindpeak
CE-IVD
Pipeline
​PD-L1 (Lung)
​Automatically identify tumorous cells in WSIs of lung tissue and quantify them to support PD-L1 scoring.
​PD-L1 (Urothelial)
​PD-L1 (Urothelial)
Tissue Type: ​Urothelial
Vendor: Mindpeak
Pipeline
​PD-L1 (Urothelial)
​Automatically identify tumorous cells in WSIs of urothelial tissue and quantify them to support PD-L1 scoring.
​Invasive Tumor Detection (PDS)
​Invasive Tumor Detection (PDS)
Tissue Type: Various
Vendor: ​Visiopharm
CE-IVD
Pipeline
​Invasive Tumor Detection (PDS)
* Automatically detect invasive tumor. The algorithm integrates into a full biomarker analysis for automatic hot spot detection, accurate biomarker quantification, and visualization of tumor heterogeneity supporting the pathologist’s decisions.
​ER/PR
​ER/PR
Tissue Type: ​Breast
Vendor: ​Mindpeak
CE-IVD
Pipeline
​ER/PR
​Automatically detect and classify ER/PR-stained tumor cells in WSIs of breast tissue within predefined regions of interest. Tumor cells are classified as not-stained (tumor negative) or stained (tumor positive). A corresponding positivity score is provided.
​HER2
​HER2
Tissue Type: ​Breast
Vendor: ​Mindpeak
CE-IVD
Pipeline
​HER2
​Automatically detect and classify HER2-stained tumor cells in WSIs of breast tissue within predefined regions of interest. Tumor cells are classified according to membrane staining as not-stained, partially stained, complete but weakly stained, complete and strongly stained. Tumor cells exhibiting only nuclear or cytoplasmic are counted as unspecified. A HER2 score is provided.
​Ki-67
​Ki-67
Tissue Type: ​Breast
Vendor: ​Mindpeak
CE-IVD
Pipeline
​Ki-67
​Automatically detect and classify Ki-67 stained tumor cells within WSIs of breast tissue and ​identify up to four tumor regions of interest according to the global scoring method. Tumor cells are classified as ​not-stained or stained. A global unweighted score and a global weighted score are provided.
 H&E Biomarker Enrichment
H&E Biomarker Enrichment
Tissue Type: ​Various
Vendor: ​Nucleai
Pipeline
H&E Biomarker Enrichment
This app enables the QC and structuring of H&E images and provides an output of cell classification, tissue area segmentation, and biomarker quantification (e.g., TILs or tumor infiltrating lymphocytes). These biomarker signatures can be applied to use cases such as mechanism of action (MOA) analysis, building an H&E data lake, biomarker discovery, clinical trial screening or trial enrollment.

Over 120 Research Applications

Contact us for more information about the over 120 additional research applications available on the Concentriq platform.

Quest Diagnostics & Ibex Study

Study Report:

Quantifying the Value of AI-Powered Digital Workflows in Real-World Diagnostic Laboratories

Gain insights on a recent collaboration with Quest Diagnostics, Ibex, and Proscia. Learn how AI-powered diagnostics, delivered through an enterprise digital pathology platform, impacted operations in a large diagnostic lab setting.

GET THE REPORT

Access Proscia’s Precision Medicine AI Portfolio

CONTACT US

*Proscia is not the legal manufacturer of these products. Certain products may only be available for diagnostic use in select geographies.

Please contact Proscia for availability of an application in your geography.

Our website uses cookies. By using this site, you agree to its use of cookies.